Staphylococcus Aureus peritonitis in Australian peritoneal dialysis patients: Predictors, treatment, and outcomes in 503 cases

Peritoneal Dialysis International

Volumn 30, Issue 3, 2010, Pages 311-319

  Govindarajulu, Sridevi ^a,b   Hawley, Carmel Mary ^a,b   Mcdonald, Stephen P ^a,c   Brown, Fiona G ^a,d   Rosman, Johan B ^a,e   Wiggins, Kathryn J ^a,f   Bannister, Kym M ^a,g   Johnson, David W ^a,b  

^a Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e MIDDLEMORE HOSPITAL   (New Zealand)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Antibiotics; Bacteria; Fungi; Microbiology; Outcomes; Peritonitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLOXACILLIN; DICLOXACILLIN; FLUCLOXACILLIN; FLUCONAZOLE; GENTAMICIN; NYSTATIN; RIFAMPICIN; STREPTOKINASE; TEICOPLANIN; UROKINASE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTERIAL PERITONITIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CATHETER REMOVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DRUG CHOICE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PATIENT; PERITONEAL DIALYSIS PATIENT; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS;

AGED; ANTI-INFECTIVE AGENTS; AUSTRALIA; CEFAZOLIN; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 77957661757     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2008.00258     Document Type: Article

References (17)

1. Johnson DW, Chang S, Excell L, Livingston B, Bannister K, McDonald SP. Peritoneal dialysis. In: McDonald SP, Excell L, eds. ANZDATA Registry Report 2006. Adelaide, South Australia: Australian and New Zealand Dialysis and Transplant Registry; 2007: 87-103.
2. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 2009; 53:290-7.
3. Szeto CC, Leung CB, Chow KM, Kwan BC, Law MC, Wang AY, et al. Change in bacterial aetiology of peritoneal dialysisrelated peritonitis over 10 years: experience from a centre in South-East Asia. Clin Microbiol Infect 2005; 11: 837-9.
4. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; 103:S55-62.
5. de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Teixeira Caramori JC, Barretti P. Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 2005; 64:378-82.
6. Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR. Outcome following staphylococcal peritonitis. Perit Dial Int 2000; 20:215-19.
7. Kim D, Tapson J, Wu G, Khanna R, Vas SI, Oreopoulos DG. Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1984; 30:494-7.
8. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52:524-9.
9. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-31.
10. Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Yu S, et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2007; 2:245-51.
11. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32:623-8.
12. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993; 13(Suppl 2):S332-4.
13. McCullagh P, Nelder JA. Generalised Linear Models. London: Chapman and Hall; 1989.
14. Bartley PB, Schooneveldt JM, Looke DF, Morton A, Johnson DW, Nimmo GR. The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital. J Hosp Infect 2001; 48:43-54.
15. Pisoni RL, Greenwood RN. Selected lessons learned from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Contrib Nephrol 2005; 149:58-68.
16. Briganti EM, Wolfe R, Russ GR, Eris JM, Walker RG, McNeil JJ. Graft loss following renal transplantation in Australia: is there a centre effect? Nephrol Dial Transplant 2002; 17:1099-104.
17. Mertz D, Frei R, Periat N, Zimmerli M, Battegay M, Fluckiger U, et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 2009; 169:172-8.